SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)
(Amendment No. 1)*
Vera Therapeutics, Inc.
(Name of Issuer)
Class A Common Stock
(Title of Class of Securities)
92337R101
(CUSIP Number)
December 31, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
(Continued on following pages)
Exhibit Index on Page 7
CUSIP #92337R101 | Page 2 of 8 |
1 | NAME OF REPORTING PERSONS Kleiner Perkins Caufield & Byers XVI, LLC (“KPCB XVI”) |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x |
3 | SEC USE ONLY |
4 | CITIZENSHIP
OR PLACE OF ORGANIZATION Delaware |
|
5 | SOLE VOTING POWER
|
6 | SHARED
VOTING POWER See response to row 5. | |
7 | SOLE
DISPOSITIVE POWER 1,298,695 shares, except that KPCB XVI Associates, the managing member of KPCB XVI, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED
DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 1,298,695 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 | 4.7% |
12 | TYPE OF REPORTING PERSON | OO |
CUSIP #92337R101 | Page 3 of 8 |
1 | NAME OF REPORTING PERSONS KPCB XVI Founders Fund, LLC (“KPCB XVI Founders”) |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x |
3 | SEC USE ONLY |
4 | CITIZENSHIP
OR PLACE OF ORGANIZATION Delaware |
|
5 | SOLE VOTING POWER
|
6 | SHARED
VOTING POWER See response to row 5. | |
7 | SOLE
DISPOSITIVE POWER 44,457 shares, except that KPCB XVI Associates, the managing member of KPCB XVI Founders, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED
DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 44,457 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 | 0.2% |
12 | TYPE OF REPORTING PERSON | OO |
CUSIP #92337R101 |
Page 4 of 8 |
1 | NAME OF REPORTING PERSONS KPCB XVI Associates, LLC |
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x |
3 | SEC USE ONLY |
4 | CITIZENSHIP
OR PLACE OF ORGANIZATION Delaware |
|
5 | SOLE VOTING POWER
|
6 | SHARED
VOTING POWER See response to row 5. | |
7 | SOLE
DISPOSITIVE POWER 1,343,152 shares, of which 1,298,695 are directly owned by KPCB XVI and 44,457 are directly owned by KPCB XVI Founders. KPCB XVI Associates, the managing member of KPCB XVI and KPCB XVI Founders, may be deemed to have sole power to dispose of these shares. | |
8 | SHARED
DISPOSITIVE POWER See response to row 7. |
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | 1,343,152 |
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | ¨ |
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 | 4.9% |
12 | TYPE OF REPORTING PERSON | OO |
CUSIP #92337R101 |
Page 5 of 8 |
This Amendment No. 1 amends the Statement on Schedule 13G previously filed by Kleiner Perkins Caufield & Byers XVI, LLC, a Delaware limited liability company, KPCB XVI Founders Fund, LLC, a Delaware limited liability company, and KPCB XVI Associates, LLC, a Delaware limited liability company. The foregoing entities are collectively referred to as the “Reporting Persons.” Only those items as to which there has been a change are included in this Amendment No. 1.
ITEM 4. | OWNERSHIP |
The following information with respect to the ownership of the ordinary shares of the Issuer by the persons filing this Statement is provided as of December 31, 2022:
(a) | Amount beneficially owned: See Row 9 of cover page for each Reporting Person. |
(b) | Percent of Class: See Row 11 of cover page for each Reporting Person. |
(c) | Number of shares as to which such person has: |
(i) | Sole power to vote or to direct the vote: See Row 5 of cover page for each Reporting Person. |
(ii) | Shared power to vote or to direct the vote: |
See Row 6 of cover page for each Reporting Person.
(iii) | Sole power to dispose or to direct the disposition of: |
See Row 7 of cover page for each Reporting Person.
(iv) | Shared power to dispose or to direct the disposition of: See Row 8 of cover page for each Reporting Person. |
ITEM 5. | OWNERSHIP
OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x |
CUSIP #92337R101 |
Page 6 of 8 |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 1, 2023
KLEINER PERKINS CAUFIELD & BYERS XVI, LLC, a Delaware limited liability company | ||
By: KPCB XVI ASSOCIATES, LLC, a Delaware limited liability company, its managing member | ||
By: | /s/ Susan Biglieri | |
Susan Biglieri | ||
Chief Financial Officer | ||
KPCB XVI FOUNDERS FUND, LLC, a Delaware limited liability company | ||
By: KPCB XVI ASSOCIATES, LLC, a Delaware limited liability company, its managing member | ||
By: | /s/ Susan Biglieri | |
Susan Biglieri | ||
Chief Financial Officer | ||
KPCB XVI ASSOCIATES, LLC, a Delaware limited liability company | ||
By: | /s/ Susan Biglieri | |
Susan Biglieri | ||
Chief Financial Officer |
CUSIP #92337R101 |
Page 7 of 8 |
EXHIBIT INDEX
Found on Sequentially | |
Exhibit | Numbered Page |
Exhibit A: Agreement of Joint Filing | 8 |
CUSIP #92337R101 |
Page 8 of 8 |
exhibit A
Agreement of Joint Filing
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock of the Issuer shall be filed on behalf of each of the undersigned. Note that a copy of the applicable Agreement of Joint Filing is already on file with the appropriate agencies.